ChargePoint Technology Acquires PuroVaso
ChargePoint Technology has acquired single-use container company PuroVaso.
ChargePoint Technology announced on August 25, 2022 that it had acquired PuroVaso, a company focused on the design, development, and manufacture of single-use containers.
According to a company press release, the acquisition is designed to complement ChargePoint’s existing portfolio of containment and sterile transfer technology. When combined with PureVaso’s single-use solutions, ChargePoint believes it can give pharmaceutical manufacturers a broader choice of powder and liquid transfer, storage, and handling products.
"PuroVaso has vast technical expertise in pharmaceutical processing, transfer, handling and storage, with a broad portfolio of products that customers rely on for critical process applications,” said Chris Eccles, CEO of ChargePoint, in a company press release. “With its extensive process knowledge, application engineered solutions, and relentless customer focus, PuroVaso offers leading solutions to highly regulated pharma and biopharma landscapes along with several other process critical markets. We are very excited to have PuroVaso join the ChargePoint portfolio of solutions.”
Source: ChargePoint
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
